28 September 2016

Loss-making Greenchip in share swap

27/09/02

Aim-listed Greenchip Investments, the bombed-out e-business backer-turned degradable plastic specialist, lost 473,500 in the six months to June and has agreed a near-350,000 share swap with the currently floating New Opportunities Investment Trust, writes Robert Tyerman.

Porter Ribb, who has replaced Malcolm Burne as executive chairman of Greenchip, says the company's net assets have increased from 1 million last year to 4.26 million following the reverse takeover of US degradable plastic innovator Programmable Life, though that figure includes goodwill of 4.1 million. Greenchip, which lost 502,100 in last year's first half and 579,200 for all of 2001, says commercial trials for the new products it has backed were initiated 'at a slower rate than the company would prefer' and blames 'global uncertainties'.

However, Ribb says Greenchip is 'in advanced discussions with an [unnamed] target acquisition' and expects to close the deal no later than next February, 'subject to financing and due diligence'. The company has, meanwhile, negotiated to swap 25 million of its own shares now languishing at 1p for 375,000 New Opportunities shares, valued at 1 each before the swap but, in fact, trading at 92.5p on their second day on the London Stock Exchange.

At a 92.5p New Opportunities price, the paper value of this deal is, thus, 347,000 rather than 375,000 although even that represents a hefty premium to the 250,000 market value of 25 million Greenchip at 1p in late 2000, they were more than 30p. Under the deal, Greenchip, which has replaced Grant Thornton with F.W.Smith Richies as auditor, cannot sell the New Opportunities shares for 90 days.

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today

 

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info

 

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

A gold medal ingredient 22/09/16

It’s hard work building a consumer brand, but Science in Sport is giving it a good go. The company has developed a range of sports nutrition products which have credibility from elite athlete users who won 34 medals at Rio.

A solid year at Brooks MacDonald 21/09/16

Fund manager Brooks MacDonald has recorded a solid year of asset growth. Funds under management grew by almost 12 per cent overall, which was a good result against a tricky market backdrop.

Styles & Wood upgraded on deal 21/09/16

Styles & Wood shares have doubled in value over the last six months as the strategy to diversify the customer base and focus on profits rather than revenue growth has gained momentum. A good set of interim results has just been followed by an earnings-enhancing acquisition.

Where's the beef? 15/09/16

Crawshaw Group shares have come crashing back to earth following a profit warning. When a highly rated growth stock hits an air pocket you run the risk of a big correction and the shares have fallen 40 per cent today.

Safestay hurt by downgrade 13/09/16

Hostel operator Safestay has released a slightly disappointing set of interim figures. Rather than becoming profitable this year there is now likely to be a small loss and the market has consequently cut back profit forecasts for the following years.

Back to basics at EKF 12/09/16

EKF Diagnostics interim results showed the benefit of refocusing on its core point-of-care (POC) diagnostics tests. Revenues were up 18 per cent, which was a welcome result after the disastrous foray into molecular diagnostics.

More News